| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Relay Therapeutics, Inc. (RLAY) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. RLAY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.45M | $28.12M | - | |
| Pres | 409.9K | $7.95M | - | |
| Other | 276.6K | $5.36M | - | |
| CFO | 213.9K | $4.15M | - | |
| Dir | 207.9K | $4.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2024 | Bergstrom Donald A74 | President, R&D | Sell | 765 | $7.70 | $5,890.50 | -0.1% | -17.4% | -63.4% | |
| Mar 27, 2024 | Rahmer Peter61 | See Remarks | Sell | 298 | $7.70 | $2,294.60 | - | -17.4% | -63.4% | |
| Mar 27, 2024 | Adams Brian71 | Chief Legal Officer | Sell | 348 | $7.70 | $2,679.60 | -0.1% | -17.4% | -63.4% | |
| Jan 29, 2024 | Rahmer Peter61 | See Remarks | Sell | 1,651 | $9.64 | $15,915.64 | -0.3% | -33.7% | -53.5% | |
| Jan 29, 2024 | Catinazzo Thomas69 | Chief Financial Officer | Sell | 2,005 | $9.64 | $19,328.20 | -0.6% | -33.7% | -53.5% | |
| Jan 29, 2024 | Bergstrom Donald A74 | President, R&D | Sell | 3,178 | $9.64 | $30,635.92 | -0.6% | -33.7% | -53.5% | |
| Jan 29, 2024 | Adams Brian71 | Chief Legal Officer | Sell | 1,929 | $9.64 | $18,595.56 | -0.6% | -33.7% | -53.5% | |
| Dec 27, 2023 | Catinazzo Thomas69 | Chief Financial Officer | Sell | 294 | $11.51 | $3,383.94 | -0.2% | -33.6% | -61.0% | |
| Dec 27, 2023 | Rahmer Peter61 | See Remarks | Sell | 244 | $11.51 | $2,808.44 | - | -33.6% | -61.0% | |
| Dec 27, 2023 | Bergstrom Donald A74 | President, R&D | Sell | 977 | $11.51 | $11,245.27 | -0.4% | -33.6% | -61.0% |